PACS
Neutral signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Unavailable or mixed. Current ratio 1.07 · operating margin 5.9%
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Supports a bullish reading. Interesting trend — weekly bias up
VENTE TOTALE: 829 780 titres (~36 092 271,79 $ US)
- Insiders
- Hancock MarkMurray Jason HulseConway Patrick Hugh
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$36,092,272
Avg sell (VWAP, 90d window) $44.73 vs last close $41.53 (-7.2%)
- Last activity
- 2026-09-15
- Liquidity
- Liquid $29,897,723/day · 20d vol
- Last synced
-
2026-09-22 21:10:46
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-16 | Jergensen Joshua | Sell | 3,498 | $43.62 | $152,576 | Form 4 |
| 2026-09-15 | Hancock Mark | Sell | 21,084 | $43.75 | $922,393 | Form 4 |
| 2026-09-14 | Hancock Mark | Sell | 6,634 | $44.91 | $297,901 | Form 4 |
| 2026-09-14 | Murray Jason Hulse | Sell | 317 | $45.03 | $14,275 | Form 4 |
| 2026-09-11 | Murray Jason Hulse | Sell | 10,529 | $45.23 | $476,190 | Form 4 |
| 2026-09-10 | Murray Jason Hulse | Sell | 8,771 | $45.16 | $396,105 | Form 4 |
| 2026-09-09 | Murray Jason Hulse | Sell | 4,758 | $43.33 | $206,147 | Form 4 |
| 2026-09-08 | Murray Jason Hulse | Sell | 21,001 | $43.59 | $915,530 | Form 4 |
| 2026-09-04 | Murray Jason Hulse | Sell | 243 | $43.14 | $10,484 | Form 4 |
| 2026-09-03 | Murray Jason Hulse | Sell | 858 | $43.11 | $36,987 | Form 4 |
| 2026-09-02 | Murray Jason Hulse | Sell | 6,348 | $43.36 | $275,274 | Form 4 |
| 2026-09-01 | Murray Jason Hulse | Sell | 1,368 | $43.05 | $58,890 | Form 4 |
| 2026-08-21 | Murray Jason Hulse | Sell | 27,590 | $44.25 | $1,220,772 | Form 4 |
| 2026-08-20 | Murray Jason Hulse | Sell | 13,879 | $44.76 | $621,259 | Form 4 |
| 2026-08-19 | Murray Jason Hulse | Sell | 67 | $44.85 | $3,005 | Form 4 |
| 2026-08-18 | Murray Jason Hulse | Sell | 66,797 | $44.18 | $2,951,138 | Form 4 |
| 2026-08-17 | Murray Jason Hulse | Sell | 74,844 | $44.27 | $3,313,374 | Form 4 |
| 2026-08-14 | Conway Patrick Hugh | Sell | 3,497 | $44.41 | $155,302 | Form 4 |
| 2026-08-12 | Jergensen Joshua | Sell | 36,375 | $45.70 | $1,662,268 | Form 4 |
| 2026-07-15 | Hancock Mark | Sell | 3,332 | $45.05 | $150,115 | Form 4 |
| 2026-07-15 | Jergensen Joshua | Sell | 233 | $45.76 | $10,662 | Form 4 |
| 2026-07-14 | Hancock Mark | Sell | 10,296 | $45.03 | $463,680 | Form 4 |
| 2026-07-09 | Hancock Mark | Sell | 4,966 | $45.06 | $223,781 | Form 4 |
| 2026-07-08 | Hancock Mark | Sell | 20,338 | $45.07 | $916,611 | Form 4 |
| 2026-07-06 | Hancock Mark | Sell | 142,163 | $45.33 | $6,444,860 | Form 4 |
| 2026-07-06 | Lewis Michelle Renee | Sell | 4,137 | $45.04 | $186,333 | Form 4 |
| 2026-07-02 | Hancock Mark | Sell | 12,825 | $45.01 | $577,290 | Form 4 |
| 2026-07-02 | Lewis Michelle Renee | Sell | 6,663 | $45.03 | $300,032 | Form 4 |
| 2026-07-01 | Hancock Mark | Sell | 6,080 | $45.02 | $273,716 | Form 4 |
| 2026-07-01 | Lewis Michelle Renee | Sell | 4,200 | $45.01 | $189,059 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Neutral signalScored 2026-09-21
Despite meaningful operational improvements in 2025 — expanding margins and better debt coverage — PACS carries a high leverage burden (D/E of 3.67) that leaves little room for error.
The first sentence of the analysis written for PACS on 2026-09-21 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 21.9% | 19.4% | 14.4% | 16.5% | 16.1% | |
| Ebit Margin | 5.9% | 3.6% | 6.7% | 9.6% | 7.4% | |
| Ebitda Margin | 6.9% | 4.6% | 7.5% | 10.5% | 8.0% | |
| Operating Profit Margin | 5.9% | 3.0% | 6.7% | 9.5% | 7.1% | |
| Pretax Profit Margin | 5.4% | 2.5% | 5.1% | 8.5% | 7.0% | |
| Continuous Operations Profit Margin | 3.6% | 1.4% | 3.6% | 6.2% | 4.1% | |
| Net Profit Margin | 3.6% | 1.4% | 3.6% | 6.2% | 4.1% | |
| Bottom Line Profit Margin | 3.6% | 1.4% | 3.6% | 6.2% | 4.1% | |
| Current Ratio | 1.068 | 0.959 | 1.580 | 1.056 | 0.000 | |
| Quick Ratio | 1.068 | 0.959 | 1.580 | 1.056 | 0.000 | |
| Solvency Ratio | 0.053 | 0.021 | 0.041 | 0.072 | 0.000 | |
| Cash Ratio | 0.197 | 0.161 | 0.161 | 0.120 | 0.000 | |
| Price To Earnings Ratio | 31.211 | 34.500 | 30.667 | 23.000 | 71.875 | |
| Price To Earnings Growth Ratio | 0.140 | -0.699 | -1.227 | 0.108 | 0.000 | |
| Forward Price To Earnings Growth Ratio | 0.140 | -0.699 | -1.227 | 0.108 | 0.000 | |
| Price To Earnings Diluted Ratio | 31.467 | 34.500 | 30.667 | 23.000 | 71.875 | |
| Price To Earnings Diluted Growth Ratio | 0.142 | -0.699 | -1.227 | 0.108 | 0.000 | |
| Price To Book Ratio | 6.333 | 2.710 | 35.927 | 54.261 | 0.000 | |
| Price To Sales Ratio | 1.134 | 0.470 | 1.110 | 1.426 | 2.960 | |
| Price To Free Cash Flow Ratio | 20.065 | 109.671 | 192.771 | 49.510 | -51.944 | |
| Price To Operating Cash Flow Ratio | 14.833 | 5.234 | 54.218 | 37.289 | 59.954 | |
| Debt To Assets Ratio | 0.622 | 0.668 | 0.798 | 0.782 | 0.000 | |
| Debt To Equity Ratio | 3.666 | 4.934 | 29.179 | 30.254 | 0.000 | |
| Debt To Capital Ratio | 0.786 | 0.831 | 0.967 | 0.968 | 0.000 | |
| Long Term Debt To Capital Ratio | 0.267 | 0.261 | 0.882 | 0.873 | 0.000 | |
| Financial Leverage Ratio | 5.898 | 7.389 | 36.543 | 38.681 | 0.000 | |
| Working Capital Turnover Ratio | 375.928 | 36.345 | 21.274 | 0.000 | 0.000 | |
| Operating Cash Flow Ratio | 0.404 | 0.375 | 0.139 | 0.191 | 0.000 | |
| Operating Cash Flow Sales Ratio | 0.076 | 0.090 | 0.020 | 0.038 | 0.049 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.739 | 0.048 | 0.281 | 0.753 | -1.154 | |
| Debt Service Coverage Ratio | 8.304 | 0.698 | 2.823 | 2.282 | 0.000 | |
| Interest Coverage Ratio | 10.915 | 2.776 | 4.162 | 8.981 | 15.794 | |
| Short Term Operating Cash Flow Coverage Ratio | 90.572 | 2.342 | 3.787 | 1.509 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.116 | 0.105 | 0.023 | 0.048 | 0.000 | |
| Capital Expenditure Coverage Ratio | 3.835 | 1.050 | 1.391 | 4.051 | 0.464 | |
| Dividend Paid And Capex Coverage Ratio | 3.835 | 0.958 | 0.505 | 1.114 | 0.324 | |
| Dividend Payout Ratio | 0.000 | 0.605 | 0.712 | 0.401 | 1.122 | |
| Enterprise Value Multiple | 25.357 | 28.206 | 26.560 | 20.874 | 0.000 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 21.9% | ▲2.5% | ▲4.3% |
| Ebit Margin | 5.9% | ▲2.3% | ▼-0.8% |
| Ebitda Margin | 6.9% | ▲2.4% | ▼-0.6% |
| Operating Profit Margin | 5.9% | ▲2.8% | ▼-0.6% |
| Pretax Profit Margin | 5.4% | ▲2.9% | ▼-0.3% |
| Continuous Operations Profit Margin | 3.6% | ▲2.3% | ▼-0.2% |
| Net Profit Margin | 3.6% | ▲2.3% | ▼-0.2% |
| Bottom Line Profit Margin | 3.6% | ▲2.3% | ▼-0.2% |
| Current Ratio | 1.068 | ▲0.109 | ▲0.135 |
| Quick Ratio | 1.068 | ▲0.109 | ▲0.135 |
| Solvency Ratio | 0.053 | ▲0.032 | ▲0.016 |
| Cash Ratio | 0.197 | ▲0.036 | ▲0.069 |
| Price To Earnings Ratio | 31.211 | ▼-3.289 | ▼-7.039 |
| Price To Earnings Growth Ratio | 0.140 | ▲0.839 | ▲0.475 |
| Forward Price To Earnings Growth Ratio | 0.140 | ▲0.839 | ▲0.475 |
| Price To Earnings Diluted Ratio | 31.467 | ▼-3.033 | ▼-6.835 |
| Price To Earnings Diluted Growth Ratio | 0.142 | ▲0.842 | ▲0.477 |
| Price To Book Ratio | 6.333 | ▲3.623 | ▼-13.513 |
| Price To Sales Ratio | 1.134 | ▲0.663 | ▼-0.286 |
| Price To Free Cash Flow Ratio | 20.065 | ▼-89.606 | ▼-43.950 |
| Price To Operating Cash Flow Ratio | 14.833 | ▲9.599 | ▼-19.473 |
| Debt To Assets Ratio | 0.622 | ▼-0.046 | ▲0.048 |
| Debt To Equity Ratio | 3.666 | ▼-1.268 | ▼-9.941 |
| Debt To Capital Ratio | 0.786 | ▼-0.046 | ▲0.075 |
| Long Term Debt To Capital Ratio | 0.267 | ▲0.006 | ▼-0.190 |
| Financial Leverage Ratio | 5.898 | ▼-1.491 | ▼-11.804 |
| Working Capital Turnover Ratio | 375.928 | ▲339.583 | ▲289.219 |
| Operating Cash Flow Ratio | 0.404 | ▲0.028 | ▲0.182 |
| Operating Cash Flow Sales Ratio | 0.076 | ▼-0.013 | ▲0.022 |
| Free Cash Flow Operating Cash Flow Ratio | 0.739 | ▲0.692 | ▲0.606 |
| Debt Service Coverage Ratio | 8.304 | ▲7.605 | ▲5.482 |
| Interest Coverage Ratio | 10.915 | ▲8.140 | ▲2.390 |
| Short Term Operating Cash Flow Coverage Ratio | 90.572 | ▲88.230 | ▲70.930 |
| Operating Cash Flow Coverage Ratio | 0.117 | ▲0.011 | ▲0.058 |
| Capital Expenditure Coverage Ratio | 3.835 | ▲2.785 | ▲1.677 |
| Dividend Paid And Capex Coverage Ratio | 3.835 | ▲2.877 | ▲2.488 |
| Dividend Payout Ratio | 0.000 | ▼-0.605 | ▼-0.568 |
| Enterprise Value Multiple | 25.358 | ▼-2.848 | ▲5.158 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $6.00B | $1.92B | $3.45B | $3.45B | $3.45B | |
| Enterprise value | $9.27B | $5.27B | $6.18B | $5.32B | $0 | |
| EV / Sales | 1.75x | 1.29x | 1.99x | 2.20x | 0.00x | |
| EV / Op. cash flow | 22.93x | 14.34x | 97.10x | 57.45x | 0.00x | |
| EV / Free cash flow | 31.02x | 300.37x | 345.24x | 76.28x | 0.00x | |
| EV / EBITDA | 25.36x | 28.21x | 26.56x | 20.87x | 0.00x | |
| Net debt / EBITDA | 8.96x | 17.91x | 11.73x | 7.33x | 0.00x | |
| Current ratio | 1.07x | 0.96x | 1.58x | 1.06x | 0.00x | |
| Income quality | 2.11x | 6.59x | 0.56x | 0.61x | 1.20x | |
| Graham number | $13 | $6 | $3 | $3 | $0 | |
| Graham net-net | -$25 | -$26 | -$19 | -$13 | $0 | |
| Tax burden | 67.3% | 54.9% | 71.7% | 72.7% | 58.9% | |
| Interest burden | 91.8% | 69.6% | 75.9% | 89.0% | 93.9% | |
| Working capital | $68.3M | -$40.2M | $265.2M | $27.3M | $0 | |
| Invested capital | $4.31B | $4.01B | $2.92B | $1.86B | $0 | |
| Return on assets | 3.4% | 1.1% | 3.2% | 6.1% | 0.0% | |
| Operating ROA | 5.7% | 2.8% | 7.0% | 0.0% | 0.0% | |
| Return on tangible assets | 3.5% | 1.1% | 3.3% | 6.3% | 0.0% | |
| Return on equity | 20.2% | 7.9% | 117.4% | 236.5% | 0.0% | |
| Return on invested capital | 4.4% | 1.5% | 4.7% | 7.7% | 0.0% | |
| Return on capital employed | 6.8% | 2.9% | 6.8% | 11.6% | 0.0% | |
| Earnings yield | 3.2% | 2.9% | 3.3% | 4.4% | 1.4% | |
| Free cash flow yield | 5.0% | 0.9% | 0.5% | 2.0% | -1.9% | |
| Capex / Op. cash flow | 26.1% | 95.2% | 71.9% | 24.7% | 215.4% | |
| Capex / Depreciation | 189.4% | 857.2% | 178.6% | 102.5% | 1734.8% | |
| Capex / Sales | 2.0% | 8.6% | 1.5% | 0.9% | 10.6% | |
| SG&A / Sales | 7.8% | 8.4% | 6.9% | 6.2% | 8.3% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.0% | 2.8% | 0.0% | 0.0% | 0.0% | |
| Intangibles / Total assets | 1.2% | 1.3% | 1.9% | 2.5% | 0.0% | |
| Days sales outstanding | 48d | 64d | 70d | 63d | 0d | |
| Days payables outstanding | 17d | 19d | 19d | 20d | 0d | |
| Operating cycle | 48d | 64d | 70d | 63d | 0d | |
| Cash conversion cycle | 31d | 45d | 51d | 43d | 0d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+211.8%EV / Sales ▲+36.1%EV / EBITDA ▼-10.1%EV / Op. cash flow ▲+8.597Earnings yield ▲+0.003Graham number ▲+6.500
Profitability
Return on equity ▲+0.124Return on assets ▲+0.024Return on invested capital ▲+0.029Return on capital employed ▲+0.039Operating ROA ▲+0.029Income quality ▼-4.477Tax burden ▲+0.124
Efficiency
Days sales outstanding ▼-15.495Days payables outstanding ▼-2.390Operating cycle ▼-15.495Cash conversion cycle ▼-13.105Capex / Sales ▼-0.066R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.109Net debt / EBITDA ▼-8.951Working capital ▲+108480000.000Invested capital ▲+293653000.000Intangibles / Total assets ▼-0.001
Change over 5 years
Valuation
Market cap ▲+73.6%EV / Sales n/aEV / EBITDA n/aEV / Op. cash flow n/aEarnings yield ▲+0.018Graham number n/a
Profitability
Return on equity n/aReturn on assets n/aReturn on invested capital n/aReturn on capital employed n/aOperating ROA n/aIncome quality ▲+0.910Tax burden ▲+0.085
Efficiency
Days sales outstanding n/aDays payables outstanding n/aOperating cycle n/aCash conversion cycle n/aCapex / Sales ▼-0.086R&D / Sales n/a
Balance-sheet strength
Current ratio n/aNet debt / EBITDA n/aWorking capital n/aInvested capital n/aIntangibles / Total assets n/a
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-09-17 Mark Hancock Sells 144,318 Shares of PACS Group (NYSE:PACS) Stock PACS Group, Inc. (NYSE: PACS - Get Free Report) Director Mark Hancock sold 144,318 shares of the stock in a transaction on Monday, September 14th. The stock was sold at an average price of $44.57, for a total transaction of $6,432,253.26. Following the transaction, the director owned 53,674,566 shares in the company, valued at approximately $2,392,275,406.62.
- 2026-09-17 Mark Hancock Sells 155,682 Shares of PACS Group (NYSE:PACS) Stock PACS Group, Inc. (NYSE: PACS - Get Free Report) Director Mark Hancock sold 155,682 shares of PACS Group stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $42.47, for a total transaction of $6,611,814.54. Following the completion of the sale, the director owned 53,518,884 shares of the company''s
- 2026-09-16 Jason Hulse Murray Sells 10,529 Shares of PACS Group (NYSE:PACS) Stock PACS Group, Inc. (NYSE: PACS - Get Free Report) CEO Jason Murray sold 10,529 shares of the stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $45.23, for a total value of $476,226.67. Following the transaction, the chief executive officer owned 54,555,566 shares in the company, valued at
- 2026-09-14 PACS Group, Inc. to Present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026 SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), announced today that it will present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026, in Nashville, TN.Jason Murray, Chief Executive Officer and Chairman of the Board; Carey Hendrickson, Chief Financial Officer; and Josh Jergensen, Chief Operating Officer, will present on the Company''s operations, growth strategy, and related information.The presentation will be web.
- 2026-09-08 PACS Expands Florida Footprint With 32-Facility Acquisition PACS plans to acquire operations of 32 Florida skilled nursing facilities, adding 4,049 licensed beds and establishing a statewide network.
- 2026-09-04 Bank of New York Mellon Corp Takes Position in PACS Group, Inc. $PACS Bank of New York Mellon Corp bought a new stake in PACS Group, Inc. (NYSE: PACS) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 192,210 shares of the company''s stock, valued at approximately $8,196,000. Bank of New York Mellon Corp
- 2026-09-01 PACS Group: The Peer Check Stopped Me From Calling It Cheap I rate PACS a Buy and value the shares at $49.58, about 17% above the August 31 closing price. Q2 revenue rose 9.1%, operating income grew 35.8%, and same-store occupancy reached 90.6%. Eduro adds 3,633 beds. My 2027 model includes $260 million of incremental revenue after a 27% haircut.
- 2026-09-01 PACS Group to Acquire Operations of 32 Facilities Across Florida and Closes on Additional Previously Announced Eduro Facilities SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) announced today that subsidiaries of the Company have entered into definitive agreements to acquire the operations of 32 skilled nursing facilities across Florida. The facilities will be leased from subsidiaries of one of our existing REIT landlords, Omega Healthcare Investors, Inc. (NYSE: OHI).The facilities have a combined 4,049 licensed skilled nursing beds and are deeply integrated into local healthcare networks throughout Florid.
- 2026-08-25 Allegion Redefines Commercial Access Control with the Schlage XE360™ Series featuring RealSync™ Persistent Wi-Fi Technology Allegion Redefines Commercial Access Control with the Schlage XE360⢠Series featuring RealSync⢠Persistent Wi-Fi Technology P
- 2026-08-25 Zacks Industry Outlook CareDx, BrightSpring and PACS CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.